Ibutamoren

AssetAlso LUM-201

Activates the ghrelin receptor to increase endogenous pulsatile growth hormone secretion and fat-free mass.

Stage: Human trials
Modality: Small molecule
Target: Insulin/IGF-1 signalling; 2
Indications: 0
Trials: 1
Developer

Indications

2

Growth hormone deficiency
Human trials, doi.org, 22 Oct 2025
Sarcopenia
Human trials, doi.org, 22 Oct 2025

In the full profile

Targets and what it contains2
Owner and partners1
Evidence for its targets3
Competitors5
Aging relevance1
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.